Articles
Brugada Syndrome: Defining the Risk in Asymptomatic Patients
Citation:
Arrhythmia & Electrophysiology Review 2016;5(3):164–9
Cardiac Resynchronisation Therapy: The Optimal QRS Duration Revisited
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):80-1
Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):90–101
Brugada Syndrome and Early Repolarisation
Citation:
Arrhythmia & Electrophysiology Review2016;5(2):84–9
The European Heart Rhythm Association: A Myriad of Benefits and Privileges
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):82
Antiarrhythmic Drug Therapy to Avoid ICD Shocks
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):117–21
Individualising Anticoagulant Therapy in Atrial Fibrillation Patients
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):102–9
Consensus Document on Supraventricular Arrhythmias: A Valuable Initiative from EHRA
Citation:
Arrhythmia & Electrophysiology Review 2016;5(1):8
The European Heart Rhythm Association: On the Move Towards the Future of Electrophysiology
Citation:
Arrhythmia & Electrophysiology Review 2016;5(1):10-1
Atrioventricular Nodal Reentrant Tachycardia
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):130–5